Correlation Between Akanda Corp and China Pharma
Can any of the company-specific risk be diversified away by investing in both Akanda Corp and China Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akanda Corp and China Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akanda Corp and China Pharma Holdings, you can compare the effects of market volatilities on Akanda Corp and China Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akanda Corp with a short position of China Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akanda Corp and China Pharma.
Diversification Opportunities for Akanda Corp and China Pharma
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Akanda and China is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Akanda Corp and China Pharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Pharma Holdings and Akanda Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akanda Corp are associated (or correlated) with China Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Pharma Holdings has no effect on the direction of Akanda Corp i.e., Akanda Corp and China Pharma go up and down completely randomly.
Pair Corralation between Akanda Corp and China Pharma
Given the investment horizon of 90 days Akanda Corp is expected to generate 0.77 times more return on investment than China Pharma. However, Akanda Corp is 1.3 times less risky than China Pharma. It trades about 0.02 of its potential returns per unit of risk. China Pharma Holdings is currently generating about -0.03 per unit of risk. If you would invest 168.00 in Akanda Corp on October 25, 2024 and sell it today you would lose (3.00) from holding Akanda Corp or give up 1.79% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akanda Corp vs. China Pharma Holdings
Performance |
| Timeline |
| Akanda Corp |
| China Pharma Holdings |
Akanda Corp and China Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akanda Corp and China Pharma
The main advantage of trading using opposite Akanda Corp and China Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akanda Corp position performs unexpectedly, China Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Pharma will offset losses from the drop in China Pharma's long position.| Akanda Corp vs. China SXT Pharmaceuticals | Akanda Corp vs. Petros Pharmaceuticals | Akanda Corp vs. GelStat Corp | Akanda Corp vs. Shuttle Pharmaceuticals |
| China Pharma vs. Universe Pharmaceuticals | China Pharma vs. Sonoma Pharmaceuticals | China Pharma vs. Akanda Corp | China Pharma vs. Halo Collective |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |